a Center for Medical Ethics & Health Policy.
b University of Pennsylvania Perelman School of Medicine; Children's Hospital of Philadelphia.
Am J Bioeth. 2019 Apr;19(4):11-18. doi: 10.1080/15265161.2019.1572811.
Classic statements of research ethics advise against permitting physician-investigators to obtain consent for research participation from patients with whom they have preexisting treatment relationships. Reluctance about "dual-role" consent reflects the view that distinct normative commitments govern physician-patient and investigator-participant relationships, and that blurring the research-care boundary could lead to ethical transgressions. However, several features of contemporary research demand reconsideration of the ethics of dual-role consent. Here, we examine three arguments advanced against dual-role consent: that it creates role conflict for the physician-investigator; that it can compromise the voluntariness of the patient-participant's consent; and that it promotes therapeutic misconceptions. Although these concerns have merit in some circumstances, they are not dispositive in all cases. Rather, their force-and the ethical acceptability of dual-role consent-varies with features of the particular study. As research participation more closely approximates usual care, it becomes increasingly acceptable, or even preferable, for physicians to seek consent for research from their own patients. It is time for a more nuanced approach to dual-role consent.
经典的研究伦理声明建议禁止医师研究者从与其有预先存在的治疗关系的患者那里获得研究参与的同意。对“双重角色”同意的不情愿反映了这样一种观点,即医师-患者和研究者-参与者关系受到不同的规范承诺的约束,并且模糊研究-护理边界可能导致违反伦理规范。然而,当代研究的几个特征要求重新考虑双重角色同意的伦理问题。在这里,我们考察了反对双重角色同意的三个论点:它为医师研究者创造了角色冲突;它可能损害患者参与者同意的自愿性;它促进了治疗误解。尽管这些担忧在某些情况下是有道理的,但在所有情况下都不是决定性的。相反,它们的力量——以及双重角色同意的伦理可接受性——随着特定研究的特征而变化。随着研究参与更接近通常的护理,医师从自己的患者那里寻求研究同意变得越来越可接受,甚至更可取。现在是时候对双重角色同意采取更细致入微的方法了。